Truncating Titin (TTN) Variants in Chemotherapy-Induced Cardiomyopathy.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of cardiac failure"
DOI: 10.1016/j.cardfail.2017.03.003
Abstract: Chemotherapy-induced cardiomyopathy (CCMP) is a complication of chemotherapy treatment occurring in 9% of patients treated with the use of anthracyclines. Currently, risk stratification is based on clinical risk factors that do not adequately account for… read more here.
Keywords: chemotherapy; truncating titin; ttn variants; chemotherapy induced ... See more keywords